Vor Biopharma Inc. — Director's Dealing 2021

Feb 5, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vor Biopharma Inc. (VOR)
CIK: 0001817229
Period of Report: 2021-02-04

Reporting Person: Beckman Daniella (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.90	2030-08-24	Common Stock (29432)		Direct
Stock Option (right to buy)	$1.90	2030-08-20	Common Stock (11764)		Direct

Footnotes

F1: 1/16th of the shares underlying the option vest or vested in equal three month period installments commencing on October 8, 2020, provided that the Reporting Person remains continuously engaged by the Issuer on each such vesting date.

F2: 1/16th of the shares underlying the option vest or vested in equal three month period installments commencing on October 1, 2020, provided that the Reporting Person remains continuously engaged by the Issuer on each such vesting date.